Insider Trading: Aegerion Pharmaceuticals Inc (AEGR.W)
AEGR.W on CBOE When Trading NASDAQ Global Select Market
60.05USD
24 May 2013
60.05USD
24 May 2013
Price Change (% chg)
$-1.05 (-1.72%)
$-1.05 (-1.72%)
Prev Close
$61.10
$61.10
Open
$61.05
$61.05
Day's High
$61.05
$61.05
Day's Low
$59.26
$59.26
Volume
1,400
1,400
Avg. Vol
2,475
2,475
52-wk High
$62.81
$62.81
52-wk Low
$13.01
$13.01
| ADVENT HEALTHCARE & LIFE SCIENCES III A L P | Options Exercised: 0 | ||
| Trade Date: | Monday, 30 Jan 2012 | Price: | 17.10 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 1,504,533 |
| Type Traded: | Direct | Net Change in Shares This Filing: | -44,114 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 151 |
| Total Shares Held: | 31,091,350 |
| 3 Mo. Net Change: | 6,160,368 |
| # New Positions: | 45 |
| # Closed Positions: | 13 |
| # Increased Positions: | 111 |
| # Reduced Positions: | 46 |
| # Net Buyers: | 65 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Scheer |
60 | 2005 | Independent Chairman of the Board |
Marc Beer |
48 | 2010 | Chief Executive Officer, Director |
Mark Fitzpatrick |
49 | 2011 | Chief Financial Officer |
Anne Cook |
50 | 2011 | Senior Vice President, General Counsel, Secretary |
Martha Carter |
59 | 2011 | Chief Regulatory Officer and Senior Vice President |
Mark Sumeray |
46 | 2011 | Chief Medical Officer |
Anne VanLent |
2013 | Director | |
Sol Barer |
2011 | Independent Director | |
Antonio Gotto |
76 | 2006 | Independent Director |
Sandford Smith |
65 | 2012 | Independent Director |
Paul Thomas |
56 | 2011 | Independent Director |
Amanda Murphy |
IR Contact Officer |

